« Back
Home /
Gandotinib

Gandotinib

Manufacturer	MedChem Express
Category	Oncology Metabolism Diabetes Glucose Homeostasis Inhibitors & Compound Libraries Small Molecules By Organ Colorectal Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	50 mg
Item no.	HY-13034-50mg
Targets	FLT3
CASRN	1229236-86-5
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Gandotinib (LY2784544) is a potent JAK2 inhibitor with IC50 of 3 nM. Gandotinib (LY2784544) also inhibits FLT3, FLT4, FGFR2, TYK2, and TRKB with IC50 of 4, 25, 32, 44, and 95 nM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	469.94
Clinical_Information	Phase 2
Manufacturers Research_Area	Cancer
Solubility	DMSO : ≥ 50 mg/mL
Isoform	FGFR2; FGFR3; JAK2; JAK3; Tyk2; VEGFR2/KDR/Flk-1; VEGFR3/Flt-4
Pathway	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-13034-50mg-safety-datasheet.pdf